Tuesday, October 20, 2026
6:00 AM-7:30 AM PT
Associate Dean Faculty of Medicine
University of Southampton
Honorary Consultant
University Hospital Southampton NHS Foundation Trust
Senior Investigator
National Institute for Health and Care Research
Senior Clinical Lead
National Respiratory Audit Programme
Southampton, United Kingdom
This symposium is not supported, endorsed, or accredited by CHEST, unless otherwise noted.
Program Description
Join us for this live educational symposium that brings interleukin (IL)-33, an emerging therapeutic target in respiratory medicine, to center stage. This program will examine the evolving role of IL-33 as both a driver of inflammation and a regulator of gene expression, highlighting its signaling pathways and contribution to the pathophysiology of chronic respiratory disease and acute infection. Attendees will gain insight into the scientific rationale for targeting IL-33 in therapeutic development, along with the latest updates from ongoing clinical investigations of biologic agents designed to modulate its activity. Our expert panel will share their perspectives through dynamic discussion and real-time engagement with the audience.
Target Audience
This educational activity has been designed to educate pulmonologists, as well as critical care, infectious disease, and emergency medicine clinicians who manage patients with chronic obstructive pulmonary disease (COPD) or acute respiratory infections.
Educational Objectives
Upon completion of this activity, participants will be better prepared to:
- Explain the pathophysiologic roles of IL-33 signaling in COPD and acute respiratory infections
- Compare the pharmacologic profiles and published evidence for emerging biologic therapies targeting IL-33 for COPD and acute respiratory infections
- Integrate emerging biologic therapies into treatment algorithms for COPD or acute respiratory infections as they become available
Physician Accreditation Statement
Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
Integritas designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must attend the live symposium/live stream and complete the posttest and program evaluation.
Fee Information & Refund/Cancellation Policy
There is no fee for this activity.
Americans With Disabilities Act
Any activity registrant who feels s/he may need accommodation based on the impact of a disability should contact Integritas at info@exchangecme.com to discuss their specific needs.
Integritas Contact Information
For information about this program, please contact us at info@exchangecme.com.
Register Now
10
2026
Eosinophilic Esophagitis in the Spotlight
Epithelial Cytokines from Disease Pathogenesis to Biologic Treatment
| Time: | 6:00 PM-7:30 PM CT |
| Venue: | ACG - Omni Nashville Hotel |
| Location: | Omni Nashville - Nashville, TN |
| Faculty: | Evan Dellon, MD, MPH; Maureen Bauer, MD; Girish Hiremath, MD, MPH |
10
2026
Eosinophilic Esophagitis in the Spotlight
Epithelial Cytokines from Disease Pathogenesis to Biologic Treatment
| Time: | 6:00 PM-7:30 PM CT |
| Venue: | Online - Virtual Live Stream |
| Location: | Online - Virtual Live Stream |
| Faculty: | Evan Dellon, MD, MPH; Maureen Bauer, MD; Girish Hiremath, MD, MPH |
20
2026
New Avenues in Hypertension
Evolving Management of Uncontrolled and Resistant Disease
| Time: | 8:30 AM-10:00 AM CT |
| Venue: | AAFP FMX - Omni Nashville Hotel |
| Location: | Omni Nashville - Nashville, TN |
| Faculty: | John M. Flack, MD, MPH; Kausik Umanath, MD, MS, FACP, FASN; Karol Watson, MD, PhD |
20
2026
New Avenues in Hypertension
Evolving Management of Uncontrolled and Resistant Disease
| Time: | 8:30 AM-10:00 AM CT |
| Venue: | Online - Virtual Live Stream |
| Location: | Online - Virtual Live Stream |
| Faculty: | John M. Flack, MD, MPH; Kausik Umanath, MD, MS, FACP, FASN; Karol Watson, MD, PhD |
20
2026
Drilling Down on Interleukin-33:
New Treatment Avenues for COPD and Acute Respiratory Infections
| Time: | 5:30 AM-7:30 AM PT |
| Venue: | Sheraton Phoenix Downtown (Phoenix Ballroom C) |
| Location: | Phoenix, AZ |
| Faculty: | Professor Tom Wilkinson, MA Cantab, MBBS, PhD, FRCP, FERS; Professor James Dodd, MBCHB, MRCP, PhD |

